AEON Biopharma Statistics Share Statistics AEON Biopharma has 11.31M
shares outstanding. The number of shares has increased by 921.61%
in one year.
Shares Outstanding 11.31M Shares Change (YoY) 921.61% Shares Change (QoQ) 7.34% Owned by Institutions (%) 99.99% Shares Floating 7.86M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 361.31K, so 3.2% of the outstanding
shares have been sold short.
Short Interest 361.31K Short % of Shares Out 3.2% Short % of Float 3.21% Short Ratio (days to cover) 2.18
Valuation Ratios The PE ratio is 0.01 and the forward
PE ratio is null.
AEON Biopharma's PEG ratio is
0.
PE Ratio 0.01 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -0.01 P/FCF Ratio -0.01 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AEON Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.11,
with a Debt / Equity ratio of -0.45.
Current Ratio 0.11 Quick Ratio 0.11 Debt / Equity -0.45 Debt / EBITDA -0.47 Debt / FCF -0.64 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $8.4M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.7, so AEON Biopharma's
price volatility has been higher than the market average.
Beta 0.7 52-Week Price Change n/a 50-Day Moving Average 0.77 200-Day Moving Average 15.31 Relative Strength Index (RSI) 40.85 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income 72.98M Net Income 42.01M EBITDA -27.73M EBIT -27.82M Earnings Per Share (EPS) 5597.28
Full Income Statement Balance Sheet The company has 13K in cash and 12.96M in
debt, giving a net cash position of -12.94M.
Cash & Cash Equivalents 13K Total Debt 12.96M Net Cash -12.94M Retained Earnings -431.6M Total Assets 13.8M Working Capital 3.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -20.29M
and capital expenditures 0, giving a free cash flow of -20.29M.
Operating Cash Flow -20.29M Capital Expenditures n/a Free Cash Flow -20.29M FCF Per Share -2703.8
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AEON does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for AEON.
Price Target $360 Price Target Difference n/a Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 26, 2025. It was a
backward
split with a ratio of 1:72.
Last Split Date Feb 26, 2025 Split Type backward Split Ratio 1:72
Scores Altman Z-Score -47.47 Piotroski F-Score 4
